Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Osteoporosis

  Free Subscription


Articles published in Osteoporos Int

Retrieve available abstracts of 430 articles:
HTML format
Text format



Single Articles


    December 2018
  1. CHE H, Breuil V, Cortet B, Paccou J, et al
    Vertebral fractures cascade: potential causes and risk factors.
    Osteoporos Int. 2018 Dec 5. pii: 10.1007/s00198-018-4793.
    PubMed     Text format     Abstract available


    November 2018
  2. NORIEGA DC
    Long-term safety and clinical performance of kyphoplasty and SpineJack(R) procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study.
    Osteoporos Int. 2018 Nov 28. pii: 10.1007/s00198-018-4773.
    PubMed     Text format     Abstract available


  3. WU Q
    Depression and antidepressant medications: both are linked to increased fracture risk.
    Osteoporos Int. 2018 Nov 28. pii: 10.1007/s00198-018-4785.
    PubMed     Text format    


  4. PIENKOWSKI D, Wood CL, Malluche HH
    Young's modulus and hardness of human trabecular bone with bisphosphonate treatment durations up to 20 years.
    Osteoporos Int. 2018 Nov 28. pii: 10.1007/s00198-018-4760.
    PubMed     Text format     Abstract available


  5. HOLMBERG T, Moller S, Rothmann MJ, Gram J, et al
    Socioeconomic status and risk of osteoporotic fractures and the use of DXA scans: data from the Danish population-based ROSE study.
    Osteoporos Int. 2018 Nov 21. pii: 10.1007/s00198-018-4768.
    PubMed     Text format     Abstract available


  6. YEAM CT, Chia S, Tan HCC, Kwan YH, et al
    A systematic review of factors affecting medication adherence among patients with osteoporosis.
    Osteoporos Int. 2018 Nov 12. pii: 10.1007/s00198-018-4759.
    PubMed     Text format     Abstract available


  7. HAMOOD R, Hamood H, Merhasin I, Keinan-Boker L, et al
    Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendations.
    Osteoporos Int. 2018 Nov 9. pii: 10.1007/s00198-018-4758.
    PubMed     Text format     Abstract available



  8. Osteoporosis Conference 2018 Birmingham, UK 2 - 4 December 2018 Abstracts.
    Osteoporos Int. 2018 Nov 7. pii: 10.1007/s00198-018-4738.
    PubMed     Text format    


    October 2018
  9. HILIGSMANN M, Reginster JY, Tosteson ANA, Bukata SV, et al
    Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Osteoporos Int. 2018 Oct 31. pii: 10.1007/s00198-018-4744.
    PubMed     Text format     Abstract available


  10. LIU B, Wu Q, Zhang S, Del Rosario A, et al
    Lithium use and risk of fracture: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2018 Oct 29. pii: 10.1007/s00198-018-4745.
    PubMed     Text format     Abstract available


  11. YU WB, Jiang XB, Liang D, Xu WX, et al
    Risk factors and score for recollapse of the augmented vertebrae after percutaneous vertebroplasty in osteoporotic vertebral compression fractures.
    Osteoporos Int. 2018 Oct 28. pii: 10.1007/s00198-018-4754.
    PubMed     Text format     Abstract available


  12. TAKACS I, Jokai E, Kovats DE, Aradi I, et al
    The first biosimilar approved for the treatment of osteoporosis: results of a comparative pharmacokinetic/pharmacodynamic study.
    Osteoporos Int. 2018 Oct 24. pii: 10.1007/s00198-018-4741.
    PubMed     Text format     Abstract available


  13. HAIDER IT, Lobos SM, Simonian N, Schnitzer TJ, et al
    Bone fragility after spinal cord injury: reductions in stiffness and bone mineral at the distal femur and proximal tibia as a function of time.
    Osteoporos Int. 2018 Oct 17. pii: 10.1007/s00198-018-4733.
    PubMed     Text format     Abstract available


  14. KANIS JA, Cooper C, Rizzoli R, Reginster JY, et al
    European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Osteoporos Int. 2018 Oct 15. pii: 10.1007/s00198-018-4704.
    PubMed     Text format     Abstract available


  15. TORRES L, Klingberg E, Nurkkala M, Carlsten H, et al
    Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4721.
    PubMed     Text format     Abstract available


  16. MERLE B, Dupraz C, Haesebaert J, Barraud L, et al
    Osteoporosis prevention: where are the barriers to improvement in a French general population? A qualitative study.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4720.
    PubMed     Text format     Abstract available


  17. ALLAIRE BT, Lu D, Johannesdottir F, Kopperdahl D, et al
    Prediction of incident vertebral fracture using CT-based finite element analysis.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4716.
    PubMed     Text format     Abstract available


  18. BIVER E, Pepe J, de Sire A, Chevalley T, et al
    Associations between radius low-frequency axial ultrasound velocity and bone fragility in elderly men and women.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4725.
    PubMed     Text format     Abstract available


    September 2018
  19. KENDLER DL, Chines A, Brandi ML, Papapoulos S, et al
    The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies.
    Osteoporos Int. 2018 Sep 22. pii: 10.1007/s00198-018-4687.
    PubMed     Text format     Abstract available


  20. MCALISTER FA, Ye C, Beaupre LA, Rowe BH, et al
    Adherence to osteoporosis therapy after an upper extremity fracture: a pre-specified substudy of the C-STOP randomized controlled trial.
    Osteoporos Int. 2018 Sep 19. pii: 10.1007/s00198-018-4702.
    PubMed     Text format     Abstract available


  21. KIM J, Kim SW, Lee SY, Kim TH, et al
    Bone mineral density in osteoporotic patients with pyogenic vertebral osteomyelitis: effect of early versus late treatment for osteoporosis.
    Osteoporos Int. 2018 Sep 17. pii: 10.1007/s00198-018-4695.
    PubMed     Text format     Abstract available


  22. AKHTAR ALI S, Ng C, Votava-Smith JK, Randolph LM, et al
    Bisphosphonate therapy in an infant with generalized arterial calcification with an ABCC6 mutation.
    Osteoporos Int. 2018 Sep 11. pii: 10.1007/s00198-018-4639.
    PubMed     Text format     Abstract available


  23. NGUYEN LT, Nguyen UDT, Nguyen TDT, Ho-Pham LT, et al
    Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
    Osteoporos Int. 2018 Sep 8. pii: 10.1007/s00198-018-4700.
    PubMed     Text format     Abstract available


  24. AL-SARI UA, Tobias JH, Clark EM
    Impact of mild and moderate/severe vertebral fractures on physical activity: a prospective study of older women in the UK.
    Osteoporos Int. 2018 Sep 7. pii: 10.1007/s00198-018-4692.
    PubMed     Text format     Abstract available


  25. MIYAOKA D, Imanishi Y, Ohara M, Hayashi N, et al
    Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency.
    Osteoporos Int. 2018 Sep 5. pii: 10.1007/s00198-018-4688.
    PubMed     Text format     Abstract available


  26. DI PAOLA M, Gatti D, Viapiana O, Cianferotti L, et al
    Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck.
    Osteoporos Int. 2018 Sep 4. pii: 10.1007/s00198-018-4686.
    PubMed     Text format     Abstract available


    August 2018
  27. BLATY T, Krueger D, Illgen R, Squire M, et al
    DXA evaluation of femoral bone mineral density and cortical width in patients with prior total knee arthroplasty.
    Osteoporos Int. 2018 Aug 31. pii: 10.1007/s00198-018-4682.
    PubMed     Text format     Abstract available


  28. SOKAL A, Elefant E, Leturcq T, Beghin D, et al
    Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study.
    Osteoporos Int. 2018 Aug 31. pii: 10.1007/s00198-018-4672.
    PubMed     Text format     Abstract available


  29. HALASI A, Kincse G, Varga J, Keri J, et al
    Tight control: a new therapeutic strategy in the management of osteoporotic patients.
    Osteoporos Int. 2018 Aug 30. pii: 10.1007/s00198-018-4674.
    PubMed     Text format     Abstract available


  30. LIU C, Wang L, Zhu R, Liu H, et al
    Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/beta-catenin signaling pathway in OVX rats.
    Osteoporos Int. 2018 Aug 27. pii: 10.1007/s00198-018-4670.
    PubMed     Text format     Abstract available


  31. SHIMIZU Y, Sawada N, Nakamura K, Watanabe Y, et al
    Menstrual and reproductive factors and risk of vertebral fractures in Japanese women: the Japan Public Health Center-based prospective (JPHC) study.
    Osteoporos Int. 2018 Aug 24. pii: 10.1007/s00198-018-4665.
    PubMed     Text format     Abstract available


  32. BARZILAY JI, Buzkova P, Cauley JA, Robbins JA, et al
    The associations of subclinical atherosclerotic cardiovascular disease with hip fracture risk and bone mineral density in elderly adults.
    Osteoporos Int. 2018 Aug 21. pii: 10.1007/s00198-018-4611.
    PubMed     Text format     Abstract available


  33. HAUGER AV, Bergland A, Holvik K, Stahle A, et al
    Osteoporosis and osteopenia in the distal forearm predict all-cause mortality independent of grip strength: 22-year follow-up in the population-based Tromso Study.
    Osteoporos Int. 2018 Aug 9. pii: 10.1007/s00198-018-4653.
    PubMed     Text format     Abstract available


  34. MAZZUCCHELLI R, Crespi Villarias N, Perez Fernandez E, Durban Reguera ML, et al
    Short-term association between outdoor air pollution and osteoporotic hip fracture.
    Osteoporos Int. 2018 Aug 9. pii: 10.1007/s00198-018-4605.
    PubMed     Text format     Abstract available


  35. XU Y, Wu Q
    Decreasing trend of bone mineral density in US multiethnic population: analysis of continuous NHANES 2005-2014.
    Osteoporos Int. 2018 Aug 8. pii: 10.1007/s00198-018-4648.
    PubMed     Text format     Abstract available


  36. GIANGREGORIO LM, Gibbs JC, Templeton JA, Adachi JD, et al
    Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture.
    Osteoporos Int. 2018 Aug 8. pii: 10.1007/s00198-018-4652.
    PubMed     Text format     Abstract available


  37. ZHANG YS, Weng WY, Xie BC, Meng Y, et al
    Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials.
    Osteoporos Int. 2018 Aug 6. pii: 10.1007/s00198-018-4649.
    PubMed     Text format     Abstract available


  38. GAMBOA A, Duaso E, Marimon P, Sandiumenge M, et al
    Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit.
    Osteoporos Int. 2018 Aug 3. pii: 10.1007/s00198-018-4622.
    PubMed     Text format     Abstract available


    July 2018
  39. FERRARI SL, Abrahamsen B, Napoli N, Akesson K, et al
    Diagnosis and management of bone fragility in diabetes: an emerging challenge.
    Osteoporos Int. 2018 Jul 31. pii: 10.1007/s00198-018-4650.
    PubMed     Text format     Abstract available


  40. MUNHOZ DA ROCHA LEMOS COSTA T, Costa FM, Hoffman Jonasson T, Aguiar Moreira C, et al
    Bone mineral density and vertebral fractures and their relationship with pulmonary dysfunction in patients with chronic obstructive pulmonary disease.
    Osteoporos Int. 2018 Jul 25. pii: 10.1007/s00198-018-4643.
    PubMed     Text format     Abstract available


  41. HIDAYAT K, Du X, Shi BM
    Sex hormone-binding globulin and risk of fracture in older adults: systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2018 Jul 24. pii: 10.1007/s00198-018-4600.
    PubMed     Text format     Abstract available


  42. KYVERNITAKIS I, Kostev K, Hadji P
    The tamoxifen paradox-influence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer.
    Osteoporos Int. 2018 Jul 21. pii: 10.1007/s00198-018-4642.
    PubMed     Text format     Abstract available


  43. SONG LJ, Wang LL, Ning L, Fan SW, et al
    A modification and validation of quantitative morphometry classification system for osteoporotic vertebral compressive fractures in mainland Chinese.
    Osteoporos Int. 2018 Jul 20. pii: 10.1007/s00198-018-4641.
    PubMed     Text format     Abstract available


  44. KANAZAWA I, Notsu M, Miyake H, Tanaka K, et al
    Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.
    Osteoporos Int. 2018 Jul 20. pii: 10.1007/s00198-018-4638.
    PubMed     Text format     Abstract available


  45. NORDKLINT AK, Almdal TP, Vestergaard P, Lundby-Christensen L, et al
    The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.
    Osteoporos Int. 2018 Jul 19. pii: 10.1007/s00198-018-4637.
    PubMed     Text format     Abstract available


  46. LIU J, Guo H, Rai P, Pinto L, et al
    Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis.
    Osteoporos Int. 2018 Jul 18. pii: 10.1007/s00198-018-4630.
    PubMed     Text format     Abstract available


  47. CHOI CK, Kweon S-, Lee Y-, Nam H-, et al
    Nonlinear association between bone mineral density and all-cause mortality: the Dong-gu study.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4386.
    PubMed     Text format     Abstract available


  48. BERGMAN J, Nordstrom A, Nordstrom P
    Bisphosphonate use after clinical fracture and risk of new fracture: response to comments by Wu et al.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4615.
    PubMed     Text format    


  49. TREISTER-GOLTZMAN Y, Friger M, Peleg R
    Does primary lactase deficiency reduce bone mineral density in postmenopausal women? A systematic review and meta-analysis.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4635.
    PubMed     Text format     Abstract available


  50. CHRISTIANSEN BA, Harrison SL, Fink HA, Lane NE, et al
    Incident fracture is associated with a period of accelerated loss of hip BMD: the Study of Osteoporotic Fractures.
    Osteoporos Int. 2018 Jul 10. pii: 10.1007/s00198-018-4606.
    PubMed     Text format     Abstract available


  51. VELLUCCI R, Terenzi R, Kanis JA, Kress HG, et al
    Understanding osteoporotic pain and its pharmacological treatment: supplementary presentation.
    Osteoporos Int. 2018 Jul 10. pii: 10.1007/s00198-018-4536.
    PubMed     Text format     Abstract available


  52. MO XB, Zhang YH, Lei SF
    Genome-wide identification of m(6)A-associated SNPs as potential functional variants for bone mineral density.
    Osteoporos Int. 2018 Jul 7. pii: 10.1007/s00198-018-4573.
    PubMed     Text format     Abstract available


  53. AMORIM T, Duraes C, Machado JC, Metsios GS, et al
    Genetic variation in Wnt/beta-catenin and ER signalling pathways in female and male elite dancers and its associations with low bone mineral density: a cross-section and longitudinal study.
    Osteoporos Int. 2018 Jul 5. pii: 10.1007/s00198-018-4610.
    PubMed     Text format     Abstract available


  54. WU QY, Yuan FL, Wang B, Li X, et al
    Comments on Bergman et al.: Bisphosphonate use after clinical fracture and risk of new fracture.
    Osteoporos Int. 2018 Jul 5. pii: 10.1007/s00198-018-4614.
    PubMed     Text format    


  55. WINZENRIETH R, Humbert L, Di Gregorio S, Bonel E, et al
    Effects of osteoporosis drug treatments on cortical and trabecular bone in the femur using DXA-based 3D modeling.
    Osteoporos Int. 2018 Jul 4. pii: 10.1007/s00198-018-4624.
    PubMed     Text format     Abstract available


  56. GALLI S, Stocchero M, Andersson M, Karlsson J, et al
    Correction to: The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2018 Jul 3. pii: 10.1007/s00198-018-4497.
    PubMed     Text format     Abstract available


  57. HO-PHAM LT, Chau PMN, Do AT, Nguyen HC, et al
    Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study.
    Osteoporos Int. 2018 Jul 2. pii: 10.1007/s00198-018-4579.
    PubMed     Text format     Abstract available


  58. SHUDO A, Kishimoto H, Takaoka K, Noguchi K, et al
    Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
    Osteoporos Int. 2018 Jul 2. pii: 10.1007/s00198-018-4621.
    PubMed     Text format     Abstract available


    June 2018
  59. LIU LC, Lu MC, Wang SY, Livneh H, et al
    Association of use of rehabilitation services with development of osteoporosis among patients with rheumatoid arthritis: a nationwide population-based cohort study.
    Osteoporos Int. 2018 Jun 27. pii: 10.1007/s00198-018-4569.
    PubMed     Text format     Abstract available


  60. SMITH BJ, Leyva MJ, Stephens LD, Aston CE, et al
    Relationship of American Indian blood quantum with osteoporosis risk: a cross-sectional study of American Indian women in Oklahoma.
    Osteoporos Int. 2018 Jun 25. pii: 10.1007/s00198-018-4594.
    PubMed     Text format     Abstract available


  61. GIORDANO S, Proietti A, Bisaccia T, Caso P, et al
    Hypovitaminosis D: comparison between patients with hip fracture and patients with vertebral fractures.
    Osteoporos Int. 2018 Jun 23. pii: 10.1007/s00198-018-4582.
    PubMed     Text format     Abstract available


  62. YOSHIMURA N, Muraki S, Oka H, Iidaka T, et al
    Do sarcopenia and/or osteoporosis increase the risk of frailty? A 4-year observation of the second and third ROAD study surveys.
    Osteoporos Int. 2018 Jun 21. pii: 10.1007/s00198-018-4596.
    PubMed     Text format     Abstract available


  63. SZAFORS P, Che H, Barnetche T, Morel J, et al
    Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis.
    Osteoporos Int. 2018 Jun 16. pii: 10.1007/s00198-018-4586.
    PubMed     Text format     Abstract available


  64. CHEN H, Lips P, Vervloet MG, van Schoor NM, et al
    Association of renal function with bone mineral density and fracture risk in the Longitudinal Aging Study Amsterdam.
    Osteoporos Int. 2018 Jun 15. pii: 10.1007/s00198-018-4592.
    PubMed     Text format     Abstract available


  65. BARTOSCH P, McGuigan FE, Akesson KE
    Progression of frailty and prevalence of osteoporosis in a community cohort of older women-a 10-year longitudinal study.
    Osteoporos Int. 2018 Jun 12. pii: 10.1007/s00198-018-4593.
    PubMed     Text format     Abstract available


  66. HARVEY NC, McCloskey E, Kanis JA, Compston J, et al
    Cost-effective but clinically inappropriate: new NICE intervention thresholds in osteoporosis (Technology Appraisal 464).
    Osteoporos Int. 2018 Jun 8. pii: 10.1007/s00198-018-4505.
    PubMed     Text format     Abstract available


  67. KANIS JA, Cooper C, Rizzoli R, Reginster JY, et al
    Review of the guideline of the American College of Physicians on the treatment of osteoporosis.
    Osteoporos Int. 2018 Jun 4. pii: 10.1007/s00198-018-4504.
    PubMed     Text format     Abstract available


  68. GUPTA MJ, Shah S, Peterson S, Baim S, et al
    Rush Fracture Liaison Service for capturing "missed opportunities" to treat osteoporosis in patients with fragility fractures.
    Osteoporos Int. 2018 Jun 4. pii: 10.1007/s00198-018-4559.
    PubMed     Text format     Abstract available


  69. RIKKONEN T, Poole K, Sirola J, Sund R, et al
    Long-term effects of functional impairment on fracture risk and mortality in postmenopausal women.
    Osteoporos Int. 2018 Jun 2. pii: 10.1007/s00198-018-4588.
    PubMed     Text format     Abstract available


  70. LOSADA E, Soldevila B, Ali MS, Martinez-Laguna D, et al
    Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
    Osteoporos Int. 2018 Jun 2. pii: 10.1007/s00198-018-4581.
    PubMed     Text format     Abstract available


  71. KIM SJ, Park HS, Lee DW, Lee JW, et al
    Is calcium phosphate augmentation a viable option for osteoporotic hip fractures?
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4572.
    PubMed     Text format     Abstract available


    May 2018
  72. CAI X, Yi X, Zhang Y, Zhang D, et al
    Genetic susceptibility of postmenopausal osteoporosis on sulfide quinone reductase-like gene.
    Osteoporos Int. 2018 May 31. pii: 10.1007/s00198-018-4575.
    PubMed     Text format     Abstract available


  73. LENCHIK L, Register TC, Russell GB, Xu J, et al
    Volumetric bone mineral density of the spine predicts mortality in African-American men with type 2 diabetes.
    Osteoporos Int. 2018 May 31. pii: 10.1007/s00198-018-4578.
    PubMed     Text format     Abstract available


  74. HOFF M, Skurtveit S, Meyer HE, Langhammer A, et al
    Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4560.
    PubMed     Text format     Abstract available


  75. SU Y, Lai FTT, Yip BHK, Leung JCS, et al
    Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4543.
    PubMed     Text format     Abstract available


  76. NGUYEN ET, Posas-Mendoza T, Siu AM, Ahn HJ, et al
    Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii.
    Osteoporos Int. 2018 May 9. pii: 10.1007/s00198-018-4553.
    PubMed     Text format     Abstract available


  77. RIZZOLI R, Biver E, Bonjour JP, Coxam V, et al
    Benefits and safety of dietary protein for bone health-an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis
    Osteoporos Int. 2018 May 8. pii: 10.1007/s00198-018-4534.
    PubMed     Text format     Abstract available


  78. GOH SSL, Lai PSM, Tan ATB, Ponnampalavanar S, et al
    Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors: supplementary presentation.
    Osteoporos Int. 2018 May 8. pii: 10.1007/s00198-018-4379.
    PubMed     Text format     Abstract available


  79. BIVER E, Durosier-Izart C, Merminod F, Chevalley T, et al
    Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal women.
    Osteoporos Int. 2018 May 3. pii: 10.1007/s00198-018-4535.
    PubMed     Text format     Abstract available


  80. XIAO X, Roohani D, Wu Q
    Genetic profiling of decreased bone mineral density in an independent sample of Caucasian women.
    Osteoporos Int. 2018 May 1. pii: 10.1007/s00198-018-4546.
    PubMed     Text format     Abstract available


    April 2018
  81. THONGPRAYOON C, Acharya P, Acharya C, Chenbhanich J, et al
    Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.
    Osteoporos Int. 2018 Apr 30. pii: 10.1007/s00198-018-4533.
    PubMed     Text format     Abstract available


  82. INDERJEETH CA, Raymond WD, Briggs AM, Geelhoed E, et al
    Implementation of the Western Australian Osteoporosis Model of Care: a fracture liaison service utilising emergency department information systems to identify patients with fragility fracture to improve current practice and reduce re-fracture rates: a
    Osteoporos Int. 2018 Apr 27. pii: 10.1007/s00198-018-4526.
    PubMed     Text format     Abstract available


  83. AHMADI N, Mao SS, Hajsadeghi F, Arnold B, et al
    The relation of low levels of bone mineral density with coronary artery calcium and mortality.
    Osteoporos Int. 2018 Apr 27. pii: 10.1007/s00198-018-4524.
    PubMed     Text format     Abstract available


  84. SHI M, Chen L, Xin Z, Wang Y, et al
    Bisphosphonates for the preservation of periprosthetic bone mineral density after total joint arthroplasty: a meta-analysis of 25 randomized controlled trials.
    Osteoporos Int. 2018 Apr 13. pii: 10.1007/s00198-018-4488.
    PubMed     Text format     Abstract available


  85. SU Y, Leung J, Kwok T
    The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2018 Apr 12. pii: 10.1007/s00198-017-4373.
    PubMed     Text format     Abstract available


  86. CLARK EM, Gooberman-Hill R, Peters TJ
    Correction to: Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes.
    Osteoporos Int. 2018 Apr 12. pii: 10.1007/s00198-018-4495.
    PubMed     Text format     Abstract available


  87. KOSTEV K
    Association between gout and osteoporosis risk in the United Kingdom.
    Osteoporos Int. 2018 Apr 10. pii: 10.1007/s00198-018-4477.
    PubMed     Text format    


  88. KOK VC
    Gout as a risk factor for osteoporosis: response to comments by Kostev.
    Osteoporos Int. 2018 Apr 10. pii: 10.1007/s00198-018-4478.
    PubMed     Text format    


  89. LIU Y, Levack AE, Marty E, Or O, et al
    Anabolic agents: what is beyond osteoporosis?
    Osteoporos Int. 2018 Apr 7. pii: 10.1007/s00198-018-4507.
    PubMed     Text format     Abstract available


  90. KEMMLER W, Shojaa M, Kohl M, von Stengel S, et al
    Exercise effects on bone mineral density in older men: a systematic review with special emphasis on study interventions.
    Osteoporos Int. 2018 Apr 5. pii: 10.1007/s00198-018-4482.
    PubMed     Text format     Abstract available


  91. VELLUCCI R, Terenzi R, Kanis JA, Kress HG, et al
    Understanding osteoporotic pain and its pharmacological treatment.
    Osteoporos Int. 2018 Apr 4. pii: 10.1007/s00198-018-4476.
    PubMed     Text format     Abstract available



  92. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  93. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Author Index.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  94. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): ESCEO Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  95. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Plenary Lectures Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  96. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Educational Lecture Abstract.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  97. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): IOF-ESCEO Symposium Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  98. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Satellite Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  99. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): ESCEO-WHO Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  100. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Oral Communication Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  101. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): EUGMS-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  102. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): ESPRM-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  103. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Meet-the-Expert Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  104. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Non-Sponsored Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  105. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Committee of National Societies Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    


  106. ROSEVEARE D
    World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Poster Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    


    March 2018
  107. BUTSCHEIDT S, Delsmann A, Rolvien T, Barvencik F, et al
    Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2.
    Osteoporos Int. 2018 Mar 29. pii: 10.1007/s00198-018-4499.
    PubMed     Text format     Abstract available


  108. WANG D, Ruan W, Peng Y, Li W, et al
    Sleep duration and the risk of osteoporosis among middle-aged and elderly adults: a dose-response meta-analysis.
    Osteoporos Int. 2018 Mar 25. pii: 10.1007/s00198-018-4487.
    PubMed     Text format     Abstract available


  109. XIAO X, Xu Y, Wu Q
    Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies.
    Osteoporos Int. 2018 Mar 25. pii: 10.1007/s00198-018-4486.
    PubMed     Text format     Abstract available


  110. KUMAGAI K, Harigane K, Kusayama Y, Tezuka T, et al
    Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison.
    Osteoporos Int. 2018 Mar 24. pii: 10.1007/s00198-018-4494.
    PubMed     Text format     Abstract available


  111. EBINA K, Hirao M, Hashimoto J, Matsuoka H, et al
    Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naive rheumatoid arthritis.
    Osteoporos Int. 2018 Mar 24. pii: 10.1007/s00198-018-4492.
    PubMed     Text format     Abstract available


  112. GRAUMAM RQ, Pinheiro MM, Nery LE, Castro CHM, et al
    Increased rate of osteoporosis, low lean mass, and fragility fractures in COPD patients: association with disease severity.
    Osteoporos Int. 2018 Mar 21. pii: 10.1007/s00198-018-4483.
    PubMed     Text format     Abstract available


  113. ALEKSOVA J, Kurniawan S, Elder GJ
    The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.
    Osteoporos Int. 2018 Mar 19. pii: 10.1007/s00198-018-4468.
    PubMed     Text format     Abstract available


  114. WU Q, Liu B, Tonmoy S
    Depression and risk of fracture and bone loss: an updated meta-analysis of prospective studies.
    Osteoporos Int. 2018 Mar 12. pii: 10.1007/s00198-018-4420.
    PubMed     Text format     Abstract available


  115. NAYLOR KE, Bradburn M, Paggiosi MA, Gossiel F, et al
    Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.
    Osteoporos Int. 2018 Mar 10. pii: 10.1007/s00198-018-4460.
    PubMed     Text format     Abstract available


  116. LEVIN VA, Jiang X, Kagan R
    Estrogen therapy for osteoporosis in the modern era.
    Osteoporos Int. 2018 Mar 8. pii: 10.1007/s00198-018-4414.
    PubMed     Text format     Abstract available


  117. LUO Y
    Bone mineral density averaged over a region of interest on femur is affected by age-related change of bone geometry.
    Osteoporos Int. 2018 Mar 5. pii: 10.1007/s00198-018-4461.
    PubMed     Text format     Abstract available


  118. SEGAUD N, Legroux I, Hazzan M, Noel C, et al
    Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Osteoporos Int. 2018 Mar 2. pii: 10.1007/s00198-018-4383.
    PubMed     Text format     Abstract available


    February 2018
  119. UENISHI K, Tokiwa M, Kato S, Shiraki M, et al
    Correction to: Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis.
    Osteoporos Int. 2018 Feb 26. pii: 10.1007/s00198-018-4449.
    PubMed     Text format     Abstract available


  120. UEI H, Tokuhashi Y, Maseda M, Nakahashi M, et al
    Multiple vertebral fractures associated with glucocorticoid-induced osteoporosis treated with teriparatide followed by kyphosis correction fusion: a case report.
    Osteoporos Int. 2018 Feb 23. pii: 10.1007/s00198-018-4425.
    PubMed     Text format     Abstract available


  121. GUIRANT L, Carlos F, Curiel D, Kanis JA, et al
    Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS).
    Osteoporos Int. 2018 Feb 20. pii: 10.1007/s00198-018-4389.
    PubMed     Text format     Abstract available


  122. KUIPER BW, Graybill S, Tate JM, Kaufman N, et al
    After the fall: improving osteoporosis treatment following hip fracture.
    Osteoporos Int. 2018 Feb 20. pii: 10.1007/s00198-018-4416.
    PubMed     Text format     Abstract available


  123. MARCUS R
    Comments on Galli et al.: The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-017-4177.
    PubMed     Text format    


  124. LEE CK, Choi SK, Shin DA, Yi S, et al
    Parkinson's disease and the risk of osteoporotic vertebral compression fracture: a nationwide population-based study.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4409.
    PubMed     Text format     Abstract available


  125. KARJALAINEN JP, Riekkinen O, Kroger H
    Pulse-echo ultrasound method for detection of post-menopausal women with osteoporotic BMD.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4408.
    PubMed     Text format     Abstract available


  126. GALLI S
    The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation: response to comments by Marcus.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4430.
    PubMed     Text format    


  127. BINKLEY N, Krueger D, de Papp AE
    Multiple vertebral fractures following osteoporosis treatment discontinuation: a case-report after long-term Odanacatib.
    Osteoporos Int. 2018 Feb 18. pii: 10.1007/s00198-018-4385.
    PubMed     Text format     Abstract available


  128. ROGERS TS, Harrison S, Judd S, Orwoll ES, et al
    Dietary patterns and longitudinal change in hip bone mineral density among older men.
    Osteoporos Int. 2018 Feb 15. pii: 10.1007/s00198-018-4388.
    PubMed     Text format     Abstract available


  129. ROUX S, Gaboury I, Gionet-Landry N, Garant MP, et al
    Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures.
    Osteoporos Int. 2018 Feb 14. pii: 10.1007/s00198-017-4374.
    PubMed     Text format     Abstract available


  130. ZHOU C, Fang L, Chen Y, Zhong J, et al
    Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Osteoporos Int. 2018 Feb 12. pii: 10.1007/s00198-018-4413.
    PubMed     Text format     Abstract available


  131. MORI Y, Kasai H, Ose A, Serada M, et al
    Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
    Osteoporos Int. 2018 Feb 8. pii: 10.1007/s00198-018-4376.
    PubMed     Text format     Abstract available


  132. LESLIE WD, Majumdar SR, Morin SN, Lix LM, et al
    Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
    Osteoporos Int. 2018 Feb 5. pii: 10.1007/s00198-018-4415.
    PubMed     Text format     Abstract available



  133. Erratum to: World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Poster Abstracts.
    Osteoporos Int. 2018 Feb 5. pii: 10.1007/s00198-017-4135.
    PubMed     Text format     Abstract available


  134. HAMDY RC, Seier E, Whalen K, Clark WA, et al
    FRAX calculated without BMD does not correctly identify Caucasian men with densitometric evidence of osteoporosis.
    Osteoporos Int. 2018 Feb 3. pii: 10.1007/s00198-017-4368.
    PubMed     Text format     Abstract available


  135. BERGMAN J, Nordstrom A, Nordstrom P
    Bisphosphonate use after clinical fracture and risk of new fracture.
    Osteoporos Int. 2018 Feb 3. pii: 10.1007/s00198-017-4367.
    PubMed     Text format     Abstract available


    January 2018
  136. KOK VC, Horng JT, Wang MN, Chen ZY, et al
    Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals.
    Osteoporos Int. 2018 Jan 30. pii: 10.1007/s00198-018-4375.
    PubMed     Text format     Abstract available


  137. WRIGHT NC, Hooker ER, Nielson CM, Ensrud KE, et al
    The epidemiology of wrist fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2018 Jan 17. pii: 10.1007/s00198-017-4349.
    PubMed     Text format     Abstract available


  138. NEWMAN M, Newman R, Hughes T, Vadher K, et al
    Is the timed loaded standing test a valid measure of back muscle endurance in people with vertebral osteoporosis?
    Osteoporos Int. 2018 Jan 10. pii: 10.1007/s00198-017-4358.
    PubMed     Text format     Abstract available


  139. MOOKIAH MRK, Rohrmeier A, Dieckmeyer M, Mei K, et al
    Feasibility of opportunistic osteoporosis screening in routine contrast-enhanced multi detector computed tomography (MDCT) using texture analysis.
    Osteoporos Int. 2018 Jan 10. pii: 10.1007/s00198-017-4342.
    PubMed     Text format     Abstract available


  140. VARAHRA A, Rodrigues IB, MacDermid JC, Bryant D, et al
    Exercise to improve functional outcomes in persons with osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2018 Jan 6. pii: 10.1007/s00198-017-4339.
    PubMed     Text format     Abstract available


    December 2017
  141. CHANG Y-, Huang C-, Hwang J-, Kuo J-, et al
    Fracture liaison services for osteoporosis in the Asia-Pacific region: current unmet needs and systematic literature review.
    Osteoporos Int. 2017 Dec 28. pii: 10.1007/s00198-017-4347.
    PubMed     Text format     Abstract available


  142. UENISHI K, Tokiwa M, Kato S, Shiraki M, et al
    Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis.
    Osteoporos Int. 2017 Dec 23. pii: 10.1007/s00198-017-4351.
    PubMed     Text format     Abstract available


  143. TAMIMI I, Nicolau B, Eimar H, Arekunnath Madathil S, et al
    Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study.
    Osteoporos Int. 2017 Dec 20. pii: 10.1007/s00198-017-4346.
    PubMed     Text format     Abstract available


  144. LUTHMAN S, Widen J, Borgstrom F
    Appropriateness criteria for treatment of osteoporotic vertebral compression fractures.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4348.
    PubMed     Text format     Abstract available


  145. VAN DEN BERG P, van Haard PMM, van der Veer E, Geusens PP, et al
    A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4340.
    PubMed     Text format     Abstract available


  146. HTET TD, Eisman JA, Elder GJ, Center JR, et al
    Worsening of soft tissue dystrophic calcification in an osteoporotic patient treated with teriparatide.
    Osteoporos Int. 2017 Dec 15. pii: 10.1007/s00198-017-4330.
    PubMed     Text format     Abstract available


  147. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis.
    Osteoporos Int. 2017 Dec 11. pii: 10.1007/s00198-017-4334.
    PubMed     Text format     Abstract available


  148. RUBIN KH, Rothmann MJ, Holmberg T, Hoiberg M, et al
    Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.
    Osteoporos Int. 2017 Dec 7. pii: 10.1007/s00198-017-4326.
    PubMed     Text format     Abstract available


  149. WATANABE R, Shiraki M, Saito M, Okazaki R, et al
    Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women.
    Osteoporos Int. 2017 Dec 7. pii: 10.1007/s00198-017-4337.
    PubMed     Text format     Abstract available


  150. BOSKEY AL, Spevak L, Ma Y, Wang H, et al
    Insights into the bisphosphonate holiday: a preliminary FTIRI study.
    Osteoporos Int. 2017 Dec 5. pii: 10.1007/s00198-017-4324.
    PubMed     Text format     Abstract available


  151. MARTIN-MERINO E, Petersen I, Hawley S, Alvarez-Gutierrez A, et al
    Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.
    Osteoporos Int. 2017 Dec 3. pii: 10.1007/s00198-017-4308.
    PubMed     Text format     Abstract available


  152. AREECKAL AS, Jayasheelan N, Kamath J, Zawadynski S, et al
    Early diagnosis of osteoporosis using radiogrammetry and texture analysis from hand and wrist radiographs in Indian population.
    Osteoporos Int. 2017 Dec 3. pii: 10.1007/s00198-017-4328.
    PubMed     Text format     Abstract available


  153. JONSSON E, Hansson-Hedblom A, Ljunggren O, Akesson K, et al
    A health economic simulation model for the clinical management of osteoporosis.
    Osteoporos Int. 2017 Dec 1. pii: 10.1007/s00198-017-4325.
    PubMed     Text format     Abstract available


    November 2017
  154. BREDEMEIER M
    Comments on Mignot et al.: bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Osteoporos Int. 2017 Nov 27. pii: 10.1007/s00198-017-4263.
    PubMed     Text format    


  155. PACCOU J, Cortet B
    Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk. Response to comments by Bredemeier.
    Osteoporos Int. 2017 Nov 27. pii: 10.1007/s00198-017-4320.
    PubMed     Text format    


  156. NOGUES X, Nolla JM, Casado E, Jodar E, et al
    Spanish consensus on treat to target for osteoporosis.
    Osteoporos Int. 2017 Nov 24. pii: 10.1007/s00198-017-4310.
    PubMed     Text format     Abstract available


  157. VRANKEN L, Wyers CE, Van der Velde RY, Janzing HM, et al
    Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service.
    Osteoporos Int. 2017 Nov 23. pii: 10.1007/s00198-017-4290.
    PubMed     Text format     Abstract available


  158. YANG L, Parimi N, Orwoll ES, Black DM, et al
    Association of incident hip fracture with the estimated femoral strength by finite element analysis of DXA scans in the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2017 Nov 22. doi: 10.1007/s00198-017-4319.
    PubMed     Text format     Abstract available


  159. WATANABE R, Tai N, Hirano J, Ban Y, et al
    Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.
    Osteoporos Int. 2017 Nov 22. doi: 10.1007/s00198-017-4314.
    PubMed     Text format     Abstract available


  160. GOH SSL, Lai PSM, Tan ATB, Ponnampalavanar S, et al
    Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Osteoporos Int. 2017 Nov 20. doi: 10.1007/s00198-017-4305.
    PubMed     Text format     Abstract available


  161. MAKITIE RE, Niinimaki R, Kakko S, Honkanen T, et al
    Defective WNT signaling associates with bone marrow fibrosis-a cross-sectional cohort study in a family with WNT1 osteoporosis.
    Osteoporos Int. 2017 Nov 16. doi: 10.1007/s00198-017-4309.
    PubMed     Text format     Abstract available


  162. JOHANSSON L, Sundh D, Nilsson M, Mellstrom D, et al
    Vertebral fractures and their association with health-related quality of life, back pain and physical function in older women.
    Osteoporos Int. 2017 Nov 15. doi: 10.1007/s00198-017-4296.
    PubMed     Text format     Abstract available


  163. CHENBHANICH J, Thongprayoon C, Atsawarungruangkit A, Phupitakphol T, et al
    Osteoporosis and bone mineral density in patients with Wilson's disease: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Nov 6. doi: 10.1007/s00198-017-4295.
    PubMed     Text format     Abstract available


  164. MODI A, Sen S, Adachi JD, Adami S, et al
    The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study.
    Osteoporos Int. 2017 Nov 6. doi: 10.1007/s00198-017-4271.
    PubMed     Text format     Abstract available


  165. AL-SARI UA, Tobias JH, Clark EM
    Self-reported everyday physical activities in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4287.
    PubMed     Text format     Abstract available


  166. KAZE AD, Rosen HN, Paik JM
    A meta-analysis of the association between body mass index and risk of vertebral fracture.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4294.
    PubMed     Text format     Abstract available


    October 2017
  167. SCHOUSBOE JT, Vo TN, Langsetmo L, Taylor BC, et al
    Predictors of change of trabecular bone score (TBS) in older men: results from the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2017 Oct 31. doi: 10.1007/s00198-017-4273.
    PubMed     Text format     Abstract available


  168. GREENSPAN SL, Vujevich K, Britton C, Herradura A, et al
    Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
    Osteoporos Int. 2017 Oct 30. doi: 10.1007/s00198-017-4286.
    PubMed     Text format     Abstract available


  169. RUPPERT K, Cauley J, Lian Y, Zgibor JC, et al
    The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study.
    Osteoporos Int. 2017 Oct 27. doi: 10.1007/s00198-017-4276.
    PubMed     Text format     Abstract available


  170. SPIERINGS J, Bours S, Peeters HRM
    A case of regional migratory osteoporosis.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4240.
    PubMed     Text format     Abstract available


  171. RATHBUN AM, Magaziner J, Shardell MD, Yerges-Armstrong LM, et al
    Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4280.
    PubMed     Text format     Abstract available


  172. SU Y, Leung J, Kwok T
    The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4277.
    PubMed     Text format     Abstract available


  173. DUNN P, Webb D, Olenginski TP
    Geisinger high-risk osteoporosis clinic (HiROC): 2013-2015 FLS performance analysis.
    Osteoporos Int. 2017 Oct 23. doi: 10.1007/s00198-017-4270.
    PubMed     Text format     Abstract available


  174. DONG XL, Yu WX, Li CM, He S, et al
    Danshen (Salvia miltiorrhiza) protects ovariectomized rats fed with high-saturated fat-sucrose diet from bone loss.
    Osteoporos Int. 2017 Oct 23. doi: 10.1007/s00198-017-4254.
    PubMed     Text format     Abstract available


  175. AHN SH, Seo DH, Kim SH, Nam MS, et al
    The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011.
    Osteoporos Int. 2017 Oct 19. doi: 10.1007/s00198-017-4257.
    PubMed     Text format     Abstract available


  176. KASTNER M, Perrier L, Munce SEP, Adhihetty CC, et al
    Complex interventions can increase osteoporosis investigations and treatment: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Oct 18. doi: 10.1007/s00198-017-4248.
    PubMed     Text format     Abstract available


  177. MALMGREN L, McGuigan F, Christensson A, Akesson KE, et al
    Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study.
    Osteoporos Int. 2017 Oct 16. doi: 10.1007/s00198-017-4221.
    PubMed     Text format     Abstract available


  178. LIN SM, Yang SH, Liang CC, Huang HK, et al
    Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Osteoporos Int. 2017 Oct 14. doi: 10.1007/s00198-017-4262.
    PubMed     Text format     Abstract available


  179. BINKLEY N, Besuyen R, Fuerst T, Skillern L, et al
    Is drug-induced bone loss acceptable in premenopausal women? A practical fracture risk modeling exercise.
    Osteoporos Int. 2017 Oct 10. doi: 10.1007/s00198-017-4258.
    PubMed     Text format     Abstract available


  180. MALLUCHE HH, Monier-Faugere MC, Blomquist G, Davenport DL, et al
    Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.
    Osteoporos Int. 2017 Oct 9. doi: 10.1007/s00198-017-4228.
    PubMed     Text format     Abstract available


  181. TSENG OL, Dawes MG, Spinelli JJ, Gotay CC, et al
    Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada.
    Osteoporos Int. 2017 Oct 9. doi: 10.1007/s00198-017-4218.
    PubMed     Text format     Abstract available


  182. RODRIGUEZ AJ, Scott D, Ebeling PR
    Comments on Li et al.: Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4246.
    PubMed     Text format    


  183. LI C, Wang Q
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men: response to comments by Rodriguez et al.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4245.
    PubMed     Text format    


  184. YANG S, Leslie WD, Luo Y, Goertzen AL, et al
    Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4232.
    PubMed     Text format     Abstract available


  185. ZANCHETTA MB, Boailchuk J, Massari F, Silveira F, et al
    Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study.
    Osteoporos Int. 2017 Oct 3. doi: 10.1007/s00198-017-4242.
    PubMed     Text format     Abstract available


  186. MACK DE, Wilson PM, Santos E, Brooks K, et al
    Standards of reporting: the use of CONSORT PRO and CERT in individuals living with osteoporosis.
    Osteoporos Int. 2017 Oct 2. doi: 10.1007/s00198-017-4249.
    PubMed     Text format     Abstract available


  187. DALLA VIA J, Daly RM, Fraser SF
    The effect of exercise on bone mineral density in adult cancer survivors: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Oct 2. doi: 10.1007/s00198-017-4237.
    PubMed     Text format     Abstract available


    September 2017
  188. FREDERIKSEN A, Abrahamsen B, Johansen PB, Sorensen HA, et al
    Danish, national cross-sectional observational study on the prevalence of prior major osteoporotic fractures in adults presenting with hip fracture-limitations and scope for fracture liaison services in prevention of hip fracture.
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4247.
    PubMed     Text format     Abstract available


  189. KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
    Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4239.
    PubMed     Text format     Abstract available


  190. HOLLOWAY KL, Mohebbi M, Betson AG, Hans D, et al
    Prediction of major osteoporotic and hip fractures in Australian men using FRAX scores adjusted with trabecular bone score.
    Osteoporos Int. 2017 Sep 23. doi: 10.1007/s00198-017-4226.
    PubMed     Text format     Abstract available


  191. WRIGHT NC, Saag KG, Dawson-Hughes B, Khosla S, et al
    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation.
    Osteoporos Int. 2017 Sep 21. doi: 10.1007/s00198-017-4207.
    PubMed     Text format     Abstract available


  192. LARSEN AU, Grimnes G, Jorde R
    The effect of high-dose vitamin D3 supplementation on bone mineral density in subjects with prediabetes.
    Osteoporos Int. 2017 Sep 18. doi: 10.1007/s00198-017-4222.
    PubMed     Text format     Abstract available


  193. BRIOT K, Geusens P, Em Bultink I, Lems WF, et al
    Inflammatory diseases and bone fragility.
    Osteoporos Int. 2017 Sep 15. doi: 10.1007/s00198-017-4189.
    PubMed     Text format     Abstract available


  194. ANSARI H, Beaton DE, Sujic R, Rotondi NK, et al
    Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program.
    Osteoporos Int. 2017 Sep 10. doi: 10.1007/s00198-017-4206.
    PubMed     Text format     Abstract available


  195. NGUYEN VT, Edmonds SW, Lou Y, Roblin DW, et al
    Validity, reliability, and responsiveness to change of the "Osteoporosis and You" knowledge scale.
    Osteoporos Int. 2017 Sep 7. doi: 10.1007/s00198-017-4204.
    PubMed     Text format     Abstract available


  196. CALLEGARI ET, Garland SM, Gorelik A, Wark JD, et al
    Erratum to: Determinants of bone mineral density in young Australian women; results from the Safe-D study.
    Osteoporos Int. 2017 Sep 6. doi: 10.1007/s00198-017-4210.
    PubMed     Text format    


  197. LAROCHE M, Talibart M, Cormier C, Roux C, et al
    Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature.
    Osteoporos Int. 2017 Sep 6. doi: 10.1007/s00198-017-4165.
    PubMed     Text format     Abstract available


  198. ROTHMANN MJ, Moller S, Holmberg T, Hojberg M, et al
    Non-participation in systematic screening for osteoporosis-the ROSE trial.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4205.
    PubMed     Text format     Abstract available


  199. MIGNOT MA, Taisne N, Legroux I, Cortet B, et al
    Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4215.
    PubMed     Text format     Abstract available


  200. KAEWBOONCHOO O, Sung FC, Lin CL, Hsu HC, et al
    Hip fracture risk in patients with burn injury: a retrospective cohort study in Taiwan.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4209.
    PubMed     Text format     Abstract available


  201. CELLI M, D'Eufemia P, Persiani P, Turchetti A, et al
    Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Osteoporos Int. 2017 Sep 2. doi: 10.1007/s00198-017-4214.
    PubMed     Text format     Abstract available


    August 2017
  202. LITWIC AE, Compston JE, Wyman A, Siris ES, et al
    Self-perception of fracture risk: what can it tell us?
    Osteoporos Int. 2017 Aug 31. doi: 10.1007/s00198-017-4200.
    PubMed     Text format     Abstract available


  203. ROUX C, Baron G, Briot K, Roux B, et al
    Management of oral bisphosphonates treatment by rheumatologists and determinants of therapeutic changes: a case-vignette-based study.
    Osteoporos Int. 2017 Aug 29. doi: 10.1007/s00198-017-4188.
    PubMed     Text format     Abstract available


  204. MALGO F, Hamdy NAT, Ticheler CHJM, Smit F, et al
    Value and potential limitations of vertebral fracture assessment (VFA) compared to conventional spine radiography: experience from a fracture liaison service (FLS) and a meta-analysis.
    Osteoporos Int. 2017 Aug 25. doi: 10.1007/s00198-017-4137.
    PubMed     Text format     Abstract available


  205. MIYAKOSHI N, Kudo D, Hongo M, Kasukawa Y, et al
    Comparison of spinal alignment, muscular strength, and quality of life between women with postmenopausal osteoporosis and healthy volunteers.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4184.
    PubMed     Text format     Abstract available


  206. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Erratum to: Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4161.
    PubMed     Text format    


  207. JOHANSSON H, Azizieh F, Al Ali N, Alessa T, et al
    FRAX- vs. T-score-based intervention thresholds for osteoporosis.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4160.
    PubMed     Text format     Abstract available


  208. SAITO T, Sterbenz JM, Malay S, Zhong L, et al
    Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.
    Osteoporos Int. 2017 Aug 2. doi: 10.1007/s00198-017-4175.
    PubMed     Text format     Abstract available


    July 2017
  209. CHOU L, Shamdasani P, Briggs AM, Cicuttini FM, et al
    Systematic scoping review of patients' perceived needs of health services for osteoporosis.
    Osteoporos Int. 2017 Jul 31. doi: 10.1007/s00198-017-4167.
    PubMed     Text format     Abstract available


  210. WILLIAMS ST, Lawrence PT, Miller KL, Crook JL, et al
    A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis.
    Osteoporos Int. 2017 Jul 30. doi: 10.1007/s00198-017-4172.
    PubMed     Text format     Abstract available


  211. KOH JH, Myong JP, Yoo J, Lim YW, et al
    Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Osteoporos Int. 2017 Jul 27. doi: 10.1007/s00198-017-4169.
    PubMed     Text format     Abstract available


  212. KAMPE AJ, Costantini A, Makitie RE, Jantti N, et al
    PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4150.
    PubMed     Text format     Abstract available


  213. MCCLUNG MR, Lippuner K, Brandi ML, Zanchetta JR, et al
    Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4140.
    PubMed     Text format     Abstract available


  214. VAN DER VELDE RY, Bours SPG, Wyers CE, Lems WF, et al
    Effect of implementation of guidelines on assessment and diagnosis of vertebral fractures in patients older than 50 years with a recent non-vertebral fracture.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4147.
    PubMed     Text format     Abstract available


  215. ZENG Y, Zhang L, Zhu W, He H, et al
    Network based subcellular proteomics in monocyte membrane revealed novel candidate genes involved in osteoporosis.
    Osteoporos Int. 2017 Jul 24. doi: 10.1007/s00198-017-4146.
    PubMed     Text format     Abstract available


  216. POP LM, Lingvay I, Yuan Q, Li X, et al
    Impact of pioglitazone on bone mineral density and bone marrow fat content.
    Osteoporos Int. 2017 Jul 22. doi: 10.1007/s00198-017-4164.
    PubMed     Text format     Abstract available


  217. NASIRI SARVI M, Luo Y
    Sideways fall-induced impact force and its effect on hip fracture risk: a review.
    Osteoporos Int. 2017 Jul 20. doi: 10.1007/s00198-017-4138.
    PubMed     Text format     Abstract available


  218. REYES C, Tebe C, Martinez-Laguna D, Ali MS, et al
    One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study.
    Osteoporos Int. 2017 Jul 16. doi: 10.1007/s00198-017-4144.
    PubMed     Text format     Abstract available


  219. DRIESSEN JHM, Knapen LM, Geusens PPMM, van den Bergh JPW, et al
    Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?
    Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4120.
    PubMed     Text format    


  220. KOSTEV K, Dombrowski S
    Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: response to Driessen et al.
    Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4139.
    PubMed     Text format    


  221. COSMAN F
    Spine fracture prevalence in a nationally representative sample of US women and men aged >/=40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014---supplementary presentation.
    Osteoporos Int. 2017 Jul 10. doi: 10.1007/s00198-017-3999.
    PubMed     Text format     Abstract available


  222. SHI L, Gao F, Sun W, Wang B, et al
    Short-term effects of extracorporeal shock wave therapy on bone mineral density in postmenopausal osteoporotic patients.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4136.
    PubMed     Text format     Abstract available


  223. NGUYEN VH
    Osteoporosis exercise knowledge and education in medicine and nursing.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4119.
    PubMed     Text format    


  224. GIANGREGORIO L, Clark R, McArthur C, Papaioannou A, et al
    Osteoporosis exercise knowledge and education in medicine and nursing: response to comments by Nguyen.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4121.
    PubMed     Text format    


  225. XUE F, Goli V, Petraro P, McMullan T, et al
    Marginal structural model to evaluate the association between cumulative osteoporosis medication and infection using claims data.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4129.
    PubMed     Text format     Abstract available


  226. CARFI A, Liperoti R, Fusco D, Giovannini S, et al
    Bone mineral density in adults with Down syndrome.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4133.
    PubMed     Text format     Abstract available


  227. HANUSCH BC, Tuck SP, McNally RJQ, Wu JJ, et al
    Does regional loss of bone density explain low trauma distal forearm fractures in men (the Mr F study)?
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4122.
    PubMed     Text format     Abstract available



  228. WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  229. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Author Index.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  230. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): ESCEO Symposia Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  231. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Meet-the-Experts Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  232. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Plenary Lectures Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  233. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Honorary Lecture Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  234. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Oral Communication Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  235. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Satellite Symposia Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  236. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Educational Lecture Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  237. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Non-sponsored Symposia Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  238. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Committee of National Societies Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  239. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): World Health Organization (WHO) Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  240. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Poster Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    


    June 2017
  241. MENDIS AS, Ganda K, Seibel MJ
    Barriers to secondary fracture prevention in primary care.
    Osteoporos Int. 2017 Jun 29. doi: 10.1007/s00198-017-4131.
    PubMed     Text format     Abstract available


  242. CALLEGARI ET, Garland SM, Gorelik A, Wark JD, et al
    Determinants of bone mineral density in young Australian women; results from the Safe-D study.
    Osteoporos Int. 2017 Jun 28. doi: 10.1007/s00198-017-4100.
    PubMed     Text format     Abstract available


  243. AMORIM T, Koutedakis Y, Nevill A, Wyon M, et al
    Bone mineral density in vocational and professional ballet dancers.
    Osteoporos Int. 2017 Jun 27. doi: 10.1007/s00198-017-4130.
    PubMed     Text format     Abstract available


  244. FISCHER S, Kapinos KA, Mulcahy A, Pinto L, et al
    Estimating the long-term functional burden of osteoporosis-related fractures.
    Osteoporos Int. 2017 Jun 24. doi: 10.1007/s00198-017-4110.
    PubMed     Text format     Abstract available


  245. LOGAN S, Thu WPP, Lay WK, Wang LY, et al
    Chronic joint pain and handgrip strength correlates with osteoporosis in mid-life women: a Singaporean cohort.
    Osteoporos Int. 2017 Jun 24. doi: 10.1007/s00198-017-4095.
    PubMed     Text format     Abstract available


  246. KURODA T, Ohta H, Onoe Y, Tsugawa N, et al
    Intake of omega-3 fatty acids contributes to bone mineral density at the hip in a younger Japanese female population.
    Osteoporos Int. 2017 Jun 23. doi: 10.1007/s00198-017-4128.
    PubMed     Text format     Abstract available


  247. MODI A, Sen S, Adachi JD, Adami S, et al
    Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS).
    Osteoporos Int. 2017 Jun 22. doi: 10.1007/s00198-017-4116.
    PubMed     Text format     Abstract available


  248. OSHAGBEMI OA, Driessen JHM, Pieffers A, Wouters EFM, et al
    Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.
    Osteoporos Int. 2017 Jun 21. doi: 10.1007/s00198-017-4115.
    PubMed     Text format     Abstract available


  249. LV F, Ma M, Liu W, Xu X, et al
    A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid.
    Osteoporos Int. 2017 Jun 16. doi: 10.1007/s00198-017-4094.
    PubMed     Text format     Abstract available


  250. WEYCKER D, Edelsberg J, Barron R, Atwood M, et al
    Predictors of near-term fracture in osteoporotic women aged >/=65 years, based on data from the study of osteoporotic fractures.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4103.
    PubMed     Text format     Abstract available


  251. WRIGHT NC, Foster PJ, Mudano AS, Melnick JA, et al
    Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4105.
    PubMed     Text format    


  252. LESLIE WD, Majumdar SR, Morin SN, Lix LM, et al
    FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4091.
    PubMed     Text format     Abstract available


  253. SVENSSON HK, Olsson L-, Hansson T, Karlsson J, et al
    The effects of person-centered or other supportive interventions in older women with osteoporotic vertebral compression fractures-a systematic review of the literature.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4099.
    PubMed     Text format     Abstract available


  254. BLANCO E, Burrows R, Reyes M, Lozoff B, et al
    Breastfeeding as the sole source of milk for 6 months and adolescent bone mineral density.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4106.
    PubMed     Text format     Abstract available


  255. LEHMANN T, Aeberli D
    Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4108.
    PubMed     Text format    


  256. SHIEK AHMAD B, Petty SJ, Gorelik A, O'Brien TJ, et al
    Bone loss with antiepileptic drug therapy: a twin and sibling study.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4098.
    PubMed     Text format     Abstract available


  257. COULSON J, Bagley L, Barnouin Y, Bradburn S, et al
    Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
    Osteoporos Int. 2017 Jun 5. doi: 10.1007/s00198-017-4104.
    PubMed     Text format     Abstract available


  258. GIFRE L, Ruiz-Gaspa S, Carrasco JL, Portell E, et al
    Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.
    Osteoporos Int. 2017 Jun 4. doi: 10.1007/s00198-017-4090.
    PubMed     Text format     Abstract available


  259. SHAH VN, Harrall KK, Shah CS, Gallo TL, et al
    Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature.
    Osteoporos Int. 2017 Jun 3. doi: 10.1007/s00198-017-4097.
    PubMed     Text format     Abstract available


  260. SAHNI S, Soedamah-Muthu SS, Weaver CM
    Higher milk intake increases fracture risk: confounding or true association?
    Osteoporos Int. 2017 Jun 1. doi: 10.1007/s00198-017-4088.
    PubMed     Text format    


    May 2017
  261. CUI L, Chen L, Xia W, Jiang Y, et al
    Vertebral fracture in postmenopausal Chinese women: a population-based study.
    Osteoporos Int. 2017 May 30. doi: 10.1007/s00198-017-4085.
    PubMed     Text format     Abstract available


  262. WRIGHT NC, Foster PJ, Mudano AS, Melnick JA, et al
    Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.
    Osteoporos Int. 2017 May 24. doi: 10.1007/s00198-017-4073.
    PubMed     Text format     Abstract available


  263. UEBELHART B, Rizzoli R, Ferrari SL
    Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates.
    Osteoporos Int. 2017 May 24. doi: 10.1007/s00198-017-4080.
    PubMed     Text format     Abstract available


  264. KESHISHIAN A, Boytsov N, Burge R, Krohn K, et al
    Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.
    Osteoporos Int. 2017 May 23. doi: 10.1007/s00198-017-4072.
    PubMed     Text format     Abstract available


  265. PEREZ-SAEZ MJ, Herrera S, Prieto-Alhambra D, Vilaplana L, et al
    Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.
    Osteoporos Int. 2017 May 11. doi: 10.1007/s00198-017-4065.
    PubMed     Text format     Abstract available


  266. LIN YC, Huang TS, Wu JS, Cheung YC, et al
    Are bilateral decubitus views necessary in assessing for vertebral compression fractures using DXA vertebral fracture assessment?
    Osteoporos Int. 2017 May 9. doi: 10.1007/s00198-017-4040.
    PubMed     Text format     Abstract available


  267. BOGL HP, Aspenberg P, Schilcher J
    Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Osteoporos Int. 2017 May 4. doi: 10.1007/s00198-017-4058.
    PubMed     Text format     Abstract available


  268. MALGO F, Hamdy NAT, Papapoulos SE, Appelman-Dijkstra NM, et al
    Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site.
    Osteoporos Int. 2017 May 2. doi: 10.1007/s00198-017-4054.
    PubMed     Text format     Abstract available


  269. LAIRD E, Molloy AM, McNulty H, Ward M, et al
    Greater yogurt consumption is associated with increased bone mineral density and physical function in older adults.
    Osteoporos Int. 2017 May 1. doi: 10.1007/s00198-017-4049.
    PubMed     Text format     Abstract available


  270. LEE JH, Kim JH, Hong AR, Kim SW, et al
    Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism.
    Osteoporos Int. 2017;28:1667-1674.
    PubMed     Text format     Abstract available


  271. ZHOU L, Song J, Yang S, Meng S, et al
    Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study.
    Osteoporos Int. 2017;28:1693-1698.
    PubMed     Text format     Abstract available


  272. MCCLUNG MR, Wagman RB, Miller PD, Wang A, et al
    Observations following discontinuation of long-term denosumab therapy.
    Osteoporos Int. 2017;28:1723-1732.
    PubMed     Text format     Abstract available


    April 2017
  273. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4009.
    PubMed     Text format     Abstract available


  274. HASEGAWA T, Kawakita A, Ueda N, Funahara R, et al
    A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRO
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4063.
    PubMed     Text format     Abstract available


  275. MCCLOSKEY EV
    Identification of vertebral fractures: a moderately severe solution?
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4042.
    PubMed     Text format    


  276. LI C, Zeng Y, Tao L, Liu S, et al
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Apr 26. doi: 10.1007/s00198-017-4050.
    PubMed     Text format     Abstract available


  277. CLARK EM, Cummings SR, Schousboe JT
    Spinal radiographs in those with back pain-when are they appropriate to diagnose vertebral fractures?
    Osteoporos Int. 2017 Apr 25. doi: 10.1007/s00198-017-4052.
    PubMed     Text format     Abstract available


  278. GUAN Y, Lv F, Meng Y, Ma D, et al
    Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study.
    Osteoporos Int. 2017 Apr 24. doi: 10.1007/s00198-017-4041.
    PubMed     Text format     Abstract available


  279. MOBERG L, Nilsson PM, Samsioe G, Sallsten G, et al
    Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women: the Malmo Diet and Cancer Study.
    Osteoporos Int. 2017 Apr 21. doi: 10.1007/s00198-017-4047.
    PubMed     Text format     Abstract available


  280. DOMBROWSKI S, Jacob L, Hadji P, Kostev K, et al
    Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4036.
    PubMed     Text format     Abstract available


  281. SATO H, Kondo N, Nakatsue T, Wada Y, et al
    High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4038.
    PubMed     Text format     Abstract available


  282. YAN J, Liu HJ, Li H, Chen L, et al
    Circulating periostin levels increase in association with bone density loss and healing progression during the early phase of hip fracture in Chinese older women.
    Osteoporos Int. 2017 Apr 5. doi: 10.1007/s00198-017-4034.
    PubMed     Text format     Abstract available


  283. RODRIGUEZ AJ, Scott D, Hodge A, English DR, et al
    Associations between hip bone mineral density, aortic calcification and cardiac workload in community-dwelling older Australians.
    Osteoporos Int. 2017 Apr 4. doi: 10.1007/s00198-017-4024.
    PubMed     Text format     Abstract available


    March 2017
  284. GALLI S, Stocchero M, Andersson M, Karlsson J, et al
    The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2017 Mar 27. doi: 10.1007/s00198-017-4004.
    PubMed     Text format     Abstract available


  285. WU J, Xu L, Lv Y, Dong L, et al
    Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women.
    Osteoporos Int. 2017 Mar 23. doi: 10.1007/s00198-017-3993.
    PubMed     Text format     Abstract available


  286. CHEN YY, Feng JY, Ting WY, Yen YF, et al
    Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.
    Osteoporos Int. 2017 Mar 22. doi: 10.1007/s00198-017-3939.
    PubMed     Text format     Abstract available


  287. MORIWAKI K, Mouri M, Hagino H
    Erratum to: Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-4006.
    PubMed     Text format    


  288. LAINE CM, Landin-Wilhelmsen K
    Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-3981.
    PubMed     Text format     Abstract available


  289. THOMPSON MJ, Aitken DA, Otahal P, Cicolini J, et al
    The relationship between cumulative lifetime ultraviolet radiation exposure, bone mineral density, falls risk and fractures in older adults.
    Osteoporos Int. 2017 Mar 20. doi: 10.1007/s00198-017-4001.
    PubMed     Text format     Abstract available


  290. LOOKER AC, Sarafrazi Isfahani N, Fan B, Shepherd JA, et al
    Trends in osteoporosis and low bone mass in older US adults, 2005-2006 through 2013-2014.
    Osteoporos Int. 2017 Mar 18. doi: 10.1007/s00198-017-3996.
    PubMed     Text format     Abstract available


  291. MOHD-TAHIR NA, Li SC
    Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3985.
    PubMed     Text format     Abstract available


  292. ASADIPOOYA K, Graves L, Greene LW
    Transient osteoporosis of the hip: review of the literature.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3952.
    PubMed     Text format     Abstract available


  293. POPP AW, Senn R, Curkovic I, Senn C, et al
    Factors associated with acute-phase response of bisphosphonate-naive or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
    Osteoporos Int. 2017 Mar 15. doi: 10.1007/s00198-017-3992.
    PubMed     Text format     Abstract available


  294. CHANG HK, Chang DG, Myong JP, Kim JH, et al
    Bone mineral density among Korean females aged 20-50 years: influence of age at menarche (The Korea National Health and Nutrition Examination Survey 2008-2011).
    Osteoporos Int. 2017 Mar 14. doi: 10.1007/s00198-017-3997.
    PubMed     Text format     Abstract available


  295. EASTELL R, Diez-Perez A
    Recommendations for the screening of adherence to oral bisphosphonates: reply to comments by Zhou and Sheng.
    Osteoporos Int. 2017 Mar 10. doi: 10.1007/s00198-017-3991.
    PubMed     Text format    


  296. ZHOU YH, Sheng ZF
    Comments on Diez-Perez et al.: Recommendations for the screening of adherence to oral bisphosphonates.
    Osteoporos Int. 2017 Mar 10. doi: 10.1007/s00198-017-3987.
    PubMed     Text format    


  297. MAJUMDAR SR, Lier DA, Hanley DA, Juby AG, et al
    Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Osteoporos Int. 2017 Mar 9. doi: 10.1007/s00198-017-3986.
    PubMed     Text format     Abstract available


  298. IMAI T, Tanaka S, Kawakami K, Miyazaki T, et al
    Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3966.
    PubMed     Text format     Abstract available


  299. MORIWAKI K, Mouri M, Hagino H
    Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3973.
    PubMed     Text format     Abstract available


  300. KERR C, Bottomley C, Shingler S, Giangregorio L, et al
    The importance of physical function to people with osteoporosis.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3911.
    PubMed     Text format     Abstract available


  301. HAN MH, Ryu JI, Kim CH, Kim JM, et al
    Influence of systemic bone mineral density on atlantoaxial subluxation in patients with rheumatoid arthritis.
    Osteoporos Int. 2017 Mar 2. doi: 10.1007/s00198-017-3972.
    PubMed     Text format     Abstract available


  302. WEI Y, Tian W, Zhang GL, Lv YW, et al
    Thoracolumbar kyphosis is associated with compressive vertebral fracture in postmenopausal women.
    Osteoporos Int. 2017 Mar 1. doi: 10.1007/s00198-017-3971.
    PubMed     Text format     Abstract available


    February 2017
  303. MERLE B, Chapurlat R, Vignot E, Thomas T, et al
    Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial.
    Osteoporos Int. 2017 Feb 28. doi: 10.1007/s00198-017-3953.
    PubMed     Text format     Abstract available


  304. TAMAKI J, Iki M, Sato Y, Kajita E, et al
    Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Osteoporos Int. 2017 Feb 27. doi: 10.1007/s00198-017-3967.
    PubMed     Text format     Abstract available


  305. DU Y, Zhao LJ, Xu Q, Wu KH, et al
    Socioeconomic status and bone mineral density in adults by race/ethnicity and gender: the Louisiana osteoporosis study.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3951.
    PubMed     Text format     Abstract available


  306. MORFELD JC, Vennedey V, Muller D, Pieper D, et al
    Patient education in osteoporosis prevention: a systematic review focusing on methodological quality of randomised controlled trials.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3946.
    PubMed     Text format     Abstract available


  307. ROUX C, Briot K
    Imminent fracture risk.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3976.
    PubMed     Text format     Abstract available


  308. LEE SH, Hsu WT, Lai CC, Esmaily-Fard A, et al
    Erratum to: Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Feb 23. doi: 10.1007/s00198-017-3938.
    PubMed     Text format    


  309. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
    Osteoporos Int. 2017 Feb 17. doi: 10.1007/s00198-017-3940.
    PubMed     Text format     Abstract available


  310. MARQUES ID, Araujo MJ, Graciolli FG, Reis LM, et al
    Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.
    Osteoporos Int. 2017 Feb 16. doi: 10.1007/s00198-017-3956.
    PubMed     Text format     Abstract available


  311. COLARES NETO GP, Pereira RM, Alvarenga JC, Takayama L, et al
    Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets.
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3949.
    PubMed     Text format     Abstract available


  312. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3927.
    PubMed     Text format    


  313. MORTON A
    A role for thiazide diuretic therapy in preventing bone loss, fracture, and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3922.
    PubMed     Text format    


  314. LEE DY, Jee JH, Cho YY, Jang JY, et al
    Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis.
    Osteoporos Int. 2017 Feb 10. doi: 10.1007/s00198-016-3892.
    PubMed     Text format     Abstract available


  315. HARVEY NC, McCloskey EV, Mitchell PJ, Dawson-Hughes B, et al
    Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.
    Osteoporos Int. 2017 Feb 7. doi: 10.1007/s00198-016-3894.
    PubMed     Text format     Abstract available


  316. BALLANE G, Cauley JA, Luckey MM, El-Hajj Fuleihan G, et al
    Worldwide prevalence and incidence of osteoporotic vertebral fractures.
    Osteoporos Int. 2017 Feb 6. doi: 10.1007/s00198-017-3909.
    PubMed     Text format     Abstract available


  317. LESPESSAILLES E, Cortet B, Legrand E, Guggenbuhl P, et al
    Low-trauma fractures without osteoporosis.
    Osteoporos Int. 2017 Feb 4. doi: 10.1007/s00198-017-3921.
    PubMed     Text format     Abstract available


  318. MIKULA AL, Hetzel SJ, Binkley N, Anderson PA, et al
    Validity of height loss as a predictor for prevalent vertebral fractures, low bone mineral density, and vitamin D deficiency.
    Osteoporos Int. 2017 Feb 3. doi: 10.1007/s00198-017-3937.
    PubMed     Text format     Abstract available


    January 2017
  319. FU SJ, Sheng ZF
    Comments on Kamimura et al.: significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
    Osteoporos Int. 2017 Jan 27. doi: 10.1007/s00198-016-3867.
    PubMed     Text format    


  320. KAMIMURA M, Nakamura Y, Ikegami S, Uchiyama S, et al
    Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments.
    Osteoporos Int. 2017 Jan 27. doi: 10.1007/s00198-017-3923.
    PubMed     Text format    


  321. OKUBO R, Sanada LS, Castania VA, Louzada MJ, et al
    Jumping exercise preserves bone mineral density and mechanical properties in osteopenic ovariectomized rats even following established osteopenia.
    Osteoporos Int. 2017 Jan 26. doi: 10.1007/s00198-017-3905.
    PubMed     Text format     Abstract available


  322. ALACREU E, Moratal D, Arana E
    Opportunistic screening for osteoporosis by routine CT in Southern Europe.
    Osteoporos Int. 2017 Jan 20. doi: 10.1007/s00198-016-3804.
    PubMed     Text format     Abstract available


  323. DIEZ-PEREZ A, Naylor KE, Abrahamsen B, Agnusdei D, et al
    International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.
    Osteoporos Int. 2017 Jan 16. doi: 10.1007/s00198-017-3906.
    PubMed     Text format     Abstract available


  324. HONG AR, Kim JH, Lee KH, Kim TY, et al
    Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3899.
    PubMed     Text format     Abstract available


  325. LIM Y, Jo K, Ha HS, Yim HW, et al
    The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3893.
    PubMed     Text format     Abstract available


  326. LEE SH, Hsu WT, Lai CC, Amin EF, et al
    Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3881.
    PubMed     Text format     Abstract available


  327. HADJI P, Boekhoff J, Hahn M, Hellmeyer L, et al
    Pregnancy-associated osteoporosis: a case-control study.
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-016-3897.
    PubMed     Text format     Abstract available


  328. MODI A, Sajjan S, Insinga R, Weaver J, et al
    Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.
    Osteoporos Int. 2017 Jan 5. doi: 10.1007/s00198-016-3886.
    PubMed     Text format     Abstract available


    December 2016
  329. JOHANSSON H, Siggeirsdottir K, Harvey NC, Oden A, et al
    Imminent risk of fracture after fracture.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3868.
    PubMed     Text format     Abstract available


  330. BURGE RT, Disch DP, Gelwicks S, Zhang X, et al
    Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3888.
    PubMed     Text format     Abstract available


  331. FAHRLEITNER-PAMMER A, Wagner D, Krisper P, Amrein K, et al
    Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  332. MANA DL, Zanchetta MB, Zanchetta JR
    Retreatment with teriparatide: our experience in three patients with severe secondary osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  333. WRIGHT NC, Saag KG, Dawson-Hughes B, Khosla S, et al
    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  334. FECHTENBAUM J, Kolta S, Briot K, Roux C, et al
    Vertebral fracture assessment by dual X-ray absorptiometry.
    Osteoporos Int. 2016.
    PubMed     Text format    


  335. RUD B, Hyldstrup L
    Vertebral fracture assessment by dual X-ray absorptiometry: reply to comments by Fechtenbaum et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  336. JUHASZ B, Gulyas K, Horvath A, Petho Z, et al
    Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  337. OTA M, Takahata M, Shimizu T, Kanehira Y, et al
    Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  338. CHEN GD, Ding D, Tian HY, Zhu YY, et al
    Adherence to the 2006 American Heart Association's Diet and Lifestyle Recommendations for cardiovascular disease risk reduction is associated with bone mineral density in older Chinese.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  339. ABDERHALDEN L, Weaver FM, Bethel M, Demirtas H, et al
    Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  340. CORREA CB, Camargos GV, Chatterjee M, Mesquita MF, et al
    Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  341. CIRNIGLIARO CM, Myslinski MJ, La Fountaine MF, Kirshblum SC, et al
    Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  342. JAMAL SA, Reid LS, Hamilton CJ
    Statement of concern re: The effects of organic nitrates on osteoporosis: a systematic review.
    Osteoporos Int. 2016.
    PubMed     Text format    


  343. JAMAL SA, Goltzman D, Hanley DA, Papaioannou A, et al
    Retraction to: Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  344. ZHANG J, Hu X, Zhang J
    Associations between serum vitamin E concentration and bone mineral density in the US elderly population.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  345. DIVASTA AD, Feldman HA, Rubin CT, Gallagher JS, et al
    The ability of low-magnitude mechanical signals to normalize bone turnover in adolescents hospitalized for anorexia nervosa.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    November 2016
  346. MAWATARI T, Muraoka R, Iwamoto Y
    Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  347. NOGUCHI T, Ebina K, Hirao M, Morimoto T, et al
    Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  348. AN T, Hao J, Sun S, Li R, et al
    Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  349. JACOB L, Kostev K
    Impact of attention deficit hyperactivity disorder therapy on fracture risk in children treated in German pediatric practices.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  350. YOSHIMURA N, Muraki S, Oka H, Iidaka T, et al
    Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  351. SANCHEZ A, Blanco R
    Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  352. KIM H, Baek KH, Lee SY, Ahn SH, et al
    Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  353. KRUSE C, Eiken P, Vestergaard P
    Clinical fracture risk evaluated by hierarchical agglomerative clustering.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  354. ZHU W, Shen H, Zhang JG, Zhang L, et al
    Cytosolic proteome profiling of monocytes for male osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  355. RAY R, Clement ND, Aitken SA, McQueen MM, et al
    High mortality in younger patients with major osteoporotic fractures.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  356. GARCIA-HOYOS M, Garcia-Unzueta MT, de Luis D, Valero C, et al
    Diverging results of areal and volumetric bone mineral density in Down syndrome.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  357. MATHAVAN N, Tagil M, Isaksson H
    Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  358. SHAH A, Prieto-Alhambra D, Hawley S, Delmestri A, et al
    Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available



  359. ABSTRACTS OF OSTEOPOROSIS CONFERENCE 2016.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  360. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Author index.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  361. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Plenary Lectures.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  362. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Oral Communications.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  363. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Poster Presentations.
    Osteoporos Int. 2016;27.
    PubMed     Text format    


    October 2016
  364. ZERBINI CA, Clark P, Mendez-Sanchez L, Pereira RM, et al
    Biologic therapies and bone loss in rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  365. BEATON DE, Vidmar M, Pitzul KB, Sujic R, et al
    Addition of a fracture risk assessment to a coordinator's role improved treatment rates within 6 months of screening in a fragility fracture screening program.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  366. BELHASSEN M, Confavreux CB, Cortet B, Lamezec L, et al
    Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  367. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Erratum to: Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the osteoporotic fractures in men (MrOS) study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  368. HARVEY NC, Biver E, Kaufman JM, Bauer J, et al
    The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Fo
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  369. TSENTIDIS C, Gourgiotis D, Kossiva L, Marmarinos A, et al
    Increased levels of Dickkopf-1 are indicative of Wnt/beta-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  370. IKI M, Fujita Y, Tamaki J, Kouda K, et al
    Incident fracture associated with increased risk of mortality even after adjusting for frailty status in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  371. HILIGSMANN M, Burlet N, Fardellone P, Al-Daghri N, et al
    Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  372. CHOI HS, Park JH, Kim SH, Shin S, et al
    Strong familial association of bone mineral density between parents and offspring: KNHANES 2008-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  373. YOSHIMURA M, Moriwaki K, Noto S, Takiguchi T, et al
    A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  374. FARMER S, Shanbhogue VV, Hansen S, Stahlberg CI, et al
    Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  375. SU Y, Leung J, Hans D, Aubry-Rozier B, et al
    Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  376. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  377. PIRRO M, Mannarino MR, Bianconi V, De Vuono S, et al
    Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  378. WALLACE ER, Siscovick DS, Sitlani CM, Dublin S, et al
    Incident atrial fibrillation and the risk of fracture in the cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  379. RODRIGUES IB, Armstrong JJ, Adachi JD, MacDermid JC, et al
    Facilitators and barriers to exercise adherence in patients with osteopenia and osteoporosis: a systematic review.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  380. KAMYCHEVA E, Goto T, Camargo CA Jr
    Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  381. MORIWAKI K, Noto S
    Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    September 2016
  382. ATTERITANO M, Di Mauro E, Canale V, Bruzzese AM, et al
    Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  383. CHEN J, Smerdely P
    Hypocalcaemia after denosumab in older people following fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  384. XU MH, Li X, Yuan FL
    Is it necessary to investigate rapamycin-modulated autophagy during the development of experimental osteoporosis in female rat?
    Osteoporos Int. 2016.
    PubMed     Text format    


  385. CHAKHTOURA M, Leslie WD, McClung M, Cheung AM, et al
    The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  386. KAMIMURA M, Nakamura Y, Ikegami S, Uchiyama S, et al
    Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  387. AVENELL A, Bolland MJ, Grey A, Reid IR, et al
    Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention.
    Osteoporos Int. 2016.
    PubMed     Text format    


  388. SMALLWOOD AJ, Schapira MM, Fedders M, Neuner JM, et al
    A pilot randomized controlled trial of a decision aid with tailored fracture risk tool delivered via a patient portal.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  389. WU X, Wei D, Sun B, Wu XN, et al
    Poor medication adherence to bisphosphonates and high self-perception of aging in elderly female patients with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  390. BALOGH R, Wood J, Dobranowski K, Lin E, et al
    Low-trauma fractures and bone mineral density testing in adults with and without intellectual and developmental disabilities: a population study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  391. NAKAMURA T, Fukunaga M, Nakano T, Kishimoto H, et al
    Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  392. PEREIRA L, Bliuc D, Stanford P, Eisman JA, et al
    More-than-minimal-trauma fractures are associated with low bone density: an 8-year prospective study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    July 2016
  393. SENAY A, Delisle J, Giroux M, Laflamme GY, et al
    The impact of a standardized order set for the management of non-hip fragility fractures in a Fracture Liaison Service.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    June 2016
  394. KARAYIANNIS PN, McAlinden MG
    Falling age-related incidence of hip fractures in women, but not men, in Northern Ireland: 2001-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    May 2016
  395. AXELSSON KF, Jacobsson R, Lund D, Lorentzon M, et al
    Effectiveness of a minimal resource fracture liaison service.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  396. SHIPMAN KE, Stammers J, Doyle A, Gittoes N, et al
    Delivering a quality-assured fracture liaison service in a UK teaching hospital-is it achievable?
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  397. MCCLUNG MR
    Cancel the denosumab holiday.
    Osteoporos Int. 2016;27:1677-82.
    PubMed     Text format    


  398. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
    Osteoporos Int. 2016;27:1869-74.
    PubMed     Text format     Abstract available


  399. PAUPITZ JA, Lima GL, Alvarenga JC, Oliveira RM, et al
    Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.
    Osteoporos Int. 2016;27:1839-48.
    PubMed     Text format     Abstract available


    April 2016
  400. TSENTIDIS C, Gourgiotis D, Kossiva L, Doulgeraki A, et al
    Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Osteoporos Int. 2016;27:1631-43.
    PubMed     Text format     Abstract available


  401. HOFFMAN V, Xue F, Gardstein B, Skerry K, et al
    Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data.
    Osteoporos Int. 2016;27:1653-8.
    PubMed     Text format     Abstract available


  402. JACQUOT J, Delion M, Gangloff S, Braux J, et al
    Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.
    Osteoporos Int. 2016;27:1401-12.
    PubMed     Text format     Abstract available


    March 2016
  403. BAE SJ, Lee SH, Ahn SH, Kim HM, et al
    The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  404. BUCKINX F, Reginster JY, Cavalier E, Petermans J, et al
    Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners.
    Osteoporos Int. 2016;27:881-6.
    PubMed     Text format     Abstract available


  405. MOSTI MP, Flemmen G, Hoff J, Stunes AK, et al
    Impaired skeletal health and neuromuscular function among amphetamine users in clinical treatment.
    Osteoporos Int. 2016;27:1003-10.
    PubMed     Text format     Abstract available


  406. ZHANG Y, Wang L, Song Y, Zhao X, et al
    Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.
    Osteoporos Int. 2016;27:1083-92.
    PubMed     Text format     Abstract available


  407. DAMIAN LO, Simon SP, Filipescu I, Bocsa C, et al
    Capillaroscopic findings in a case of Hajdu-Cheney syndrome.
    Osteoporos Int. 2016;27:1269-73.
    PubMed     Text format     Abstract available


  408. DUDLEY-JAVOROSKI S, Petrie MA, McHenry CL, Amelon RE, et al
    Bone architecture adaptations after spinal cord injury: impact of long-term vibration of a constrained lower limb.
    Osteoporos Int. 2016;27:1149-60.
    PubMed     Text format     Abstract available


    February 2016
  409. DRIESSEN JH, Hansen L, Eriksen SA, van Onzenoort HA, et al
    The epidemiology of fractures in Denmark in 2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  410. LAM FM, Bui M, Yang FZ, Pang MY, et al
    Chronic effects of stroke on hip bone density and tibial morphology: a longitudinal study.
    Osteoporos Int. 2016;27:591-603.
    PubMed     Text format     Abstract available


  411. VIAENE L, Behets GJ, Heye S, Claes K, et al
    Inflammation and the bone-vascular axis in end-stage renal disease.
    Osteoporos Int. 2016;27:489-97.
    PubMed     Text format     Abstract available


  412. HWANGBO Y, Kim JH, Kim SW, Park YJ, et al
    High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.
    Osteoporos Int. 2016;27:457-62.
    PubMed     Text format     Abstract available


  413. KAWALILAK CE, Johnston JD, Cooper DM, Olszynski WP, et al
    Role of endocortical contouring methods on precision of HR-pQCT-derived cortical micro-architecture in postmenopausal women and young adults.
    Osteoporos Int. 2016;27:789-96.
    PubMed     Text format     Abstract available


  414. KHEIR V, Munier FL, Aubry-Rozier B, Schorderet DF, et al
    Potential blindness in children of patients with hereditary bone disease.
    Osteoporos Int. 2016;27:841-4.
    PubMed     Text format     Abstract available


  415. TAN J, Fu X, Sun CG, Liu C, et al
    A single CT-guided percutaneous intraosseous injection of thermosensitive simvastatin/poloxamer 407 hydrogel enhances vertebral bone formation in ovariectomized minipigs.
    Osteoporos Int. 2016;27:757-67.
    PubMed     Text format     Abstract available


    January 2016
  416. DREW S, Judge A, Cooper C, Javaid MK, et al
    Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  417. LEIB ES, Winzenrieth R
    Bone status in glucocorticoid-treated men and women.
    Osteoporos Int. 2016;27:39-48.
    PubMed     Text format     Abstract available


  418. MATUTE-LLORENTE A, Gonzalez-Aguero A, Gomez-Cabello A, Tous-Fajardo J, et al
    Effect of whole-body vibration training on bone mass in adolescents with and without Down syndrome: a randomized controlled trial.
    Osteoporos Int. 2016;27:181-91.
    PubMed     Text format     Abstract available


  419. EASTELL R, Dijk DJ, Small M, Greenwood A, et al
    Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial.
    Osteoporos Int. 2016;27:309-18.
    PubMed     Text format     Abstract available


    December 2015
  420. NAKAYAMA A, Major G, Holliday E, Attia J, et al
    Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  421. RUDANG R, Zoulakis M, Sundh D, Brisby H, et al
    Bone material strength is associated with areal BMD but not with prevalent fractures in older women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    November 2015
  422. SENAY A, Delisle J, Raynauld JP, Morin SN, et al
    Agreement between physicians' and nurses' clinical decisions for the management of the fracture liaison service (4iFLS): the Lucky Bone program.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  423. BEALL DP, Feldman RG, Gordon ML, Gruber BL, et al
    Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  424. SUMIDA K, Ubara Y, Hoshino J, Mise K, et al
    Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    October 2015
  425. SELGA J, Nunez JH, Minguell J, Lalanza M, et al
    Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  426. RAMCHAND SK, Chiang CY, Zebaze RM, Seeman E, et al
    Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    August 2015
  427. EDWARDS BJ, Gradishar WJ, Smith ME, Pacheco JA, et al
    Elevated incidence of fractures in women with invasive breast cancer.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  428. HOLZMUELLER CG, Karp S, Zeldow D, Lee DB, et al
    Development of a cloud-based application for the Fracture Liaison Service model of care.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  429. YONG JH, Masucci L, Hoch JS, Sujic R, et al
    Cost-effectiveness of a fracture liaison service-a real-world evaluation after 6 years of service provision.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  430. LESLIE WD, Brennan-Olsen SL, Morin SN, Lix LM, et al
    Fracture prediction from repeat BMD measurements in clinical practice.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: